BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | May 12, 2022
Politics, Policy & Law

Russia boycott includes CAR T therapies

Behind Miltenyi Biotec’s decision to stop sales of vectors for CAR T therapy to Russia to protest war
BioCentury | Aug 31, 2018
Clinical News

FDA approves first drug for neurotrophic keratitis

BioCentury | Aug 16, 2017
Clinical News

EC approves Dompe's Oxervate for keratitis

Items per page:
1 - 5 of 5